Frontline azacitidine (AZA) or intensive chemotherapy (ICTx) in older AML patients. Methods: Results of 9720 were compared with results from similar patient populations treated on 3 other CALGB trials ...

Over the course of treatment, patients with relapsed/refractory acute myeloid leukemia (AML) may acquire new TP53 mutations, making ongoing monitoring for mutations crucial. “New novel therapies ...